Overview


According to FutureWise analysis the market for digital pathology is expected to reach US$ 2.66 billion by 2031 at a CAGR of 13.90%.

Acquisition, management, dissemination, and interpretation of pathology data, including data and slides, are all included in digital pathology. Glass slides are scanned using scanning technology to produce digital slides, which are high-resolution digital images that may be viewed on a computer or mobile device. Digital pathology software solutions can be used to share digital slides over networks. In order to assess and quantify the expression of biomarkers in tissue sections, automated image analysis technologies can also be used. Pathologists may engage, assess, and cooperate quickly, remotely, transparently, and consistently thanks to digital pathology, which boosts productivity and efficiency. Computer-aided diagnosis (CAD), personalized treatment, and improved translational research may someday be a part of the future of digital pathology.

Nowadays, digital pathology, along with virtual microscopy, is one of the most often employed concepts in modern pathology. Using an image-based environment known as "digital pathology," sometimes known as "virtual microscopy," pathology data can be collected, handled, and analyzed using digitalized glass slides. In the management of chronic and infectious diseases, including cancer, cardiovascular disease, and hepatitis, digital pathology is being used more and more frequently. Projects to sell accessible digital pathology systems have increased in number. Throughout the forecast period, there will likely be a significant increase in teleconsultations, which will boost the growth of the digital pathology market. The practice of human pathology, drug development, and tissue-based research are all aided by digital pathology.

FutureWise Market Research has published a report that provides an insightful analysis of digital pathology market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, the digital pathology market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.
  • Leica Biosystems 
  • Koninklijke Philips N.V.
  • Hamamatsu Photonics
  • Roche
  • 3DHistech 
  • Apollo Enterprise Imaging 
  • Xifin
  • Huron Digital Pathology
  • Visiopharm A/S
  • Corista
  • Indica Labs
  • Objective Pathology Services
  • Sectra AB
  • OptraScan
  • Glencoe Software
  • Konfoong Biotech International Co., Ltd
  • Inspirata, Inc.
  • Mikroscan Technologies
  • Proscia Inc
  • Kanteron Systems

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Digital Pathology Market:

June 2022- Roche has introduced, and CE-IVD marked the most recent Ventana DP 600 slide scanner for digital pathology

Increased teleconsultations, growing acceptance of the technology to boost lab productivity, and growing use in drug discovery and companion diagnostics are all factors driving the market for digital pathology. Due to its integration with digital tools, specimen tracking, barcoding, and digital dictation, the use of digital pathology in disease diagnosis is increasing. Increasing telepathology use, rising healthcare costs in developed countries, and a greater focus on drug research are all expected to support the market. As a result, the market is anticipated to develop over the forecast period due to a number of factors, including a rise in the use of digital pathology to boost lab productivity, rising teleconsultation rates, and rising applications in drug discovery and companion diagnostics. Moreover, the rapid technological advancement of digital pathology systems is also projected to drive market expansion. Innovations like digital imaging, computerization, robotic light microscopy, and many fiber optic networking are also helping the progress. Whole slide imaging is one such method that has a number of advantages over conventional light microscopes and is predicted to have a positive financial impact on this sector. As there is a greater emphasis on improving patient care through the application of AI to various healthcare services, such as pathological diagnostics, the usage of AI in healthcare is growing. The expanding need for researcher collaboration and the expansion of digital documentation across all scientific disciplines are driving its acceptance. Key manufacturers' increased market penetration in the developing region is predicted to drive the market. However, the current shortage of board-certified pathologists poses a hurdle to the market for digital pathology. This is because using image analysis and digital imaging technologies to create digital images of tissue samples necessitates the evaluation of those images by experienced specialists in the field of digital pathology. The lack of skilled professionals raises questions about the authenticity of digital pathology results and the quality of care. Additionally, it limits the use of digital pathology in clinical settings.

By Product

  • Software
  • Device
      o Scanners
      o Slide Management System
  • Storage Systems

By Type

  • Human Pathology
  • Veterinary Pathology

By Application

  • Disease Diagnosis
  • Drug Discovery and Development
  • Academic Research

By End User

  • Pharmaceutical and Biotechnology Companies
  • Hospitals and Reference Laboratories
  • Academic and Research Institutes

By Region

  • North America
  • Latin America
  • Europe
  • Asia-Pacific
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. The market in this area is primarily driven by the ongoing deployment of R&D investments, supportive government efforts pertaining to the development of technologically advanced systems, increased acceptance of digital imaging, and the presence of large competitors. The improvement of cancer diagnostic quality combined with increased utilization of digital pathology for disease diagnosis and favorable reimbursement policies in the U.S. are anticipated to further boost the regional market growth.

Additionally based on end-user; pharmaceutical & biotechnology companies hold highest market share. The growing usage of digital pathology for drug discovery research and drug toxicology testing is responsible for a significant share of this market. Digital pathology is also used by biotechnology firms for biobanking, biopharmaceutical research, molecular testing, and the creation of personalised medication.
  • Tier 1 players- established companies in the market with major market share
  • Tier 2 players
  • New Entrants
  • Emerging players which are growing rapidly
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data points affecting market growth
  • To provide with an exhaustive analysis on the Digital Pathology Market By Product, By Type, By Application, By End-user and By Region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections which are represented in the format of data-sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches.
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Digital Pathology Market Variables, Trends and Scope

    •        1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Digital Pathology Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Digital Pathology Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Digital Pathology Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Software
        2. Device
         2.1. Scanners
         2.2. Slide Management System
        3. Storage Systems

  • 8.   Digital Pathology Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Human Pathology
        2. Veterinary Pathology

  • 9.   Digital Pathology Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Disease Diagnosis
        2. Drug Discovery and Development
        3. Academic Research

  • 10.   Digital Pathology Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Pharmaceutical and Biotechnology Companies
        2. Hospitals and Reference Laboratories
        3. Academic and Research Institutes

  • 11.   North America Digital Pathology Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Digital Pathology Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Digital Pathology Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Digital Pathology Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

    •   1. Leica Biosystems
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Koninklijke Philips N.V.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Hamamatsu Photonics
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Roche
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. 3DHistech
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Apollo Enterprise Imaging
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Xifin
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Huron Digital Pathology
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Visiopharm A/S
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Corista
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
          11. Indica Labs
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
         12. Objective Pathology Services
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
          13. Sectra AB
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
          14. OptraScan
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
          15. Glencoe Software
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
          16. Konfoong Biotech International Co., Ltd
         16.1. Company Overview
         16.2. Product Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview
          17. Inspirata, Inc.
         17.1. Company Overview
         17.2. Product Portfolio
         17.3. SWOT Analysis
         17.4. Financial Overview
         17.5. Strategic Overview
          18. Mikroscan Technologies
         18.1. Company Overview
         18.2. Product Portfolio
         18.3. SWOT Analysis
         18.4. Financial Overview
         18.5. Strategic Overview
          19. Proscia Inc
         19.1. Company Overview
         19.2. Product Portfolio
         19.3. SWOT Analysis
         19.4. Financial Overview
         19.5. Strategic Overview
          20. Kanteron Systems
         20.1. Company Overview
         20.2. Product Portfolio
         20.3. SWOT Analysis
         20.4. Financial Overview
         20.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 19.   FutureWise SME Key Takeaway Points for Client

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11